EGFR mutation in malignant pleural effusion of non-small cell lung cancer

VernacularTitle:非小细胞肺癌患者恶性胸腔积液中EGFR基因突变
Author: Huili CHU ; Xiuju HANG ; Jingwang BI
Publication Type:Journal Article
Keywords: Carcinoma,non-small cell lung; Receptor,epidermal growth factor; Mutation; Malignant pleural effusion
From: Journal of International Oncology 2013;40(8):595-597
CountryChina
Language:Chinese
Abstract: EGFR testing has become the consensus before epidermal growth factor-tyrosine kinase inhibitorrs (EGFR-TKIs) treatment in non-small cell lung cancer(NSCLC) patients.Malignant pleural effusion is the common clinical manifestation in NSCLC patients,and EGFR testing by using different methods in pleural effusion cells and free nucleic acids has good prospect for predicting the efficacy of EGFR-TKIs.